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Introduction: Chronic granulomatous disease, one of the primary immunodeficiency syndromes, is characterized by
failure of phagocytic capacity due to loss of reactive oxygen species production, as well as formation of granulomas in
organs. Clinically, dysregulated inflammation by excessive cytokine production due to loss of reactive oxygen species
production is suggested as a cause of noninfectious inflammatory problems such as chronic granulomatous disease
colitis. We experienced a rare case of a patient with chronic granulomatous disease with unique pathological and
radiological presentations of hypersensitive pneumonitis, which to our knowledge has never been previously reported.
Case presentation: A 20-year-old Japanese man with chronic granulomatous disease was referred due to cough and
abnormal chest imaging findings. Computed tomography of his chest showed diffuse, bilateral, centrilobular nodules
and multiple mass lesions in lower lobes that do not fit a common image of hypersensitivity pneumonitis. Pathological
findings of both nodules and mass lesions on surgical lung biopsy were homogeneous, and excessive granulomas in the
bronchioles and alveolar duct as well as lymphocytic alveolitis were seen, all consistent with hypersensitivity pneumonitis.
The radiological and laboratory abnormalities did not improve after antigen avoidance; however, they disappeared after
high-dose steroid therapy.
Conclusions: When we encounter a case of hypersensitive pneumonitis showing atypical pulmonary mass-like opacities
in a patient with chronic granulomatous disease, we should consider hyperinflammatory status and excessive granuloma
formation of chronic granulomatous disease and start with high-dose steroid therapy as treatment.Introduction
Chronic granulomatous disease (CGD) is a hereditary
immunodeficiency disease characterized by failure of
phagocytic capacity due to a defect of nicotinamide ad-
enine dinucleotide phosphate reactive oxygen species
production and lack of bacterial killing, which causes re-
current life-threatening infections. The mechanism for
granuloma formation remains unclear, but the neutro-
philic response persists for an abnormally long period at
sources of inflammation and results in chronic inflam-
mation. However, reactive oxygen species also regulate
cell signaling by activating nuclear factor-κB and other
transcription factors and the production of cytokines
such as interleukin-1β and tumor necrosis factor-α, even* Correspondence: katsuya-tky@umin.ac.jp
1National Center for Global Health and Medicine, Division of Respiratory
Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
Full list of author information is available at the end of the article
© 2014 Katsuya et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.in nonphagocytic cells. Clinically, dysregulated inflam-
mation by excessive cytokine production due to loss of
reactive oxygen species production is suggested as a
cause of noninfectious inflammatory problems such as
CGD colitis [1,2]. Here, we report unusual pathological
and radiological presentations of hypersensitive pneu-
monitis in a patient with CGD, which have never been
reported.Case presentation
A 20-year-old Japanese man was referred due to nonpro-
ductive cough and abnormal findings on chest imaging.
His mother was a heterozygous carrier of CGD, and he
was diagnosed as having X-linked recessive CGD lacking
gp91phox at the age of 1 year. He was given prophylaxis
with trimethoprim-sulfamethoxazole and itraconazole andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Computed tomography of the chest. Computed tomography of the chest shows diffuse bilateral fine centrilobular nodules, as well
as some mass lesions in lower lobes that do not fit a common image of hypersensitivity pneumonitis.
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developed CGD-related colitis and started treatment with
prednisone 45mg per day. He started working at a ware-
house 4 months later. After 3 months, a routine chest
X-ray showed abnormalities. He then developed a non-
productive cough unresponsive to either antibiotics or
antifungals.
On admission, his oxygen saturation at rest was 92%,
and there were end-inspiratory crackles on auscultation
of both lung bases. Results of laboratory tests showed a
white blood cell count of 11,380/mm3, C-reactive pro-
tein of 4.67mg/dL, erythrocyte sedimentation rate of
37mm after 1 hour, and a serum KL-6 of 3824U/mL.
Lactase dehydrogenase and angiotensin-conversion en-
zyme levels were within the normal range. Screening for
cytomegalovirus antigen and QuantiFERON®-TB Gold
(Cellestis Limited, Carnegie, Victoria, Australia) were
negative, as were rheumatoid factor, antineutrophilic
cytoplasmic antibody, antinuclear antibody and anti-Jo-1
antibody. Pulmonary function studies showed that first-
second vital capacity was 2.68L (86.2% predicted), a vital
capacity of 3.25L (72.5% predicted), a ratio of residualFigure 2 The surgical specimen of a mass-like opacity in the left lower
bronchiole and alveolar duct (left) and in the lymph tract just below the pleu
with hypersensitivity pneumonitis with poor drainage of a large amount of gvolume to total lung capacity of 25.8%, and a single-
breath carbon monoxide diffusing capacity of 64.5% pre-
dicted. The serum precipitins reaction test was 2+ for
Aspergillus species except Aspergillus niger and negative
for Trichosporon asahii. A chest radiograph showed
bilateral fine reticulonodular shadow in his lower
lung areas. Computed tomography of his chest revealed
bilateral diffuse fine centrilobular nodules and some
mass lesions in lower lobes that do not fit a common
image of hypersensitivity pneumonitis, but no lesions in
interstitial areas (Figure 1). Bronchoalveolar lavage fluid
from his right middle lobe consisted of 37% macrophages
and 62% T cells, with a CD4 to CD8 ratio of 0.84. Fungal
and mycobacterial cultures of bronchoalveolar lavage fluid
were negative, as were polymerase chain reactions for tuber-
culosis, nontuberculous Mycobacterium, and Pneumocystis
jirovecii. A transbronchial lung biopsy from his right middle
lobe demonstrated small, loosely formed, non-necrotizing
granulomas surrounded by slight collagenous fibers with
or without giant cells in the bronchioles and alveolar duct,
as well as lymphocytic alveolitis. These features were
consistent with hypersensitivity pneumonitis.lobe. Small, loose-formed, non-necrotizing granulomas are seen in the
ra (right); no granulomatous vasculitis is seen. The findings are consistent
ranulomas (Elastica van Gieson stain, left ×200, right ×100).
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his oxygen saturation returned to normal in 3 weeks;
however, centrilobular nodules persisted on computed
tomography, the mass lesions enlarged, and his serum
KL-6 was still high at 4000U/mL. As a diagnostic
procedure, a surgical biopsy of a mass lesion was per-
formed. The specimen revealed massive granulomas
spreading not only in alveolar ducts, as in the trans-
bronchial lung biopsy findings, but also in the lymph
tract just below the pleura. Granulomatous vasculitis
was not evident, and these findings were consistent
with poor drainage of a large amount of granulomas
(Figure 2).
Considering the negative findings for infectious dis-
ease, high-dose steroid therapy was started. The centri-
lobular nodules then disappeared, the mass lesions
shrank, and his serum KL-6 decreased.
Discussion
According to the analysis of 25 CGD surgical specimens,
granulomas in patients with CGD were typically 100μm
or less in diameter and contained central neutrophil
microabcesses surrounded by a layer of palisading epi-
thelioid histiocytes and giant cells. They spread not only
in airways, but also in lung parenchyma. In the same
specimens, Aspergillus species were isolated in 44% and
bacterial organisms were cultured in 28% [3,4].
In this case, the following three differential diagnoses
of mass-like opacities were considered: CGD, fungal or
bacterial infection, and hypersensitivity pneumonitis.
First, the granulomas were loosely formed and relatively
larger than those of CGD, they did not contain central
microabcesses, and they spread through the airway
to the lymph tract, consistent with hypersensitivity
pneumonitis. Second, bacterial or fungal infection was
proven neither histologically nor bacteriologically. Al-
though no inhaled antigen was proven, his past history
of working at a warehouse indicated that fungal expos-
ure might have caused hypersensitivity pneumonitis.
Recent reports show an excessive release of inflammatory
cytokines such as from neutrophils in patients with CGD
[5]. Animal models of CGD also show the hyperinflamed
immune dysregulation seen in CGD, which explain exces-
sive granuloma formation in organs such as the gastrointes-
tinal system and the genitourinary system [6]. Experiments
performed in this case showed that the patient’s T cells in
the bronchoalveolar lavage fluid produced excessive cyto-
kines after incubation with or without antigen stimulation
in vitro (data not shown). These findings lead to the pos-
sibility that excessive inflammation in T cells of patients
with CGD explains atypical granuloma formation, such
as the homogeneous and excessive amount of loose-
formed granulomas through the airway spreading into
the lymph tracts, despite the subacute clinical course.Conclusions
When we encounter a case of hypersensitive pneumon-
itis showing atypical pulmonary mass-like opacities in a
patient with CGD, we should consider hyperinflamma-
tory status and excessive granuloma formation of CGD
and start with high-dose steroid therapy as treatment.
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